CHEMICAL/BIOLOGICAL DEFENSE (OP SYS DEV)

Abstract

The projects in this program element (PE) support efforts to upgrade systems that have been fielded or have received approval for full rate production in order to maintain Joint Force readiness. Individual projects include: - Contamination Avoidance (CA7): technology refresh of fielded analytical laboratory system capabilities to conduct on-site analysis of any unknown sample and test potential life-threatening substances. - Homeland Defense (CM7): technology refresh of fielded analytical laboratory system capabilities to conduct on-site analysis of any unknown sample and test potential life-threatening substances. - Collective Protection (CO7): technology upgrade and refresh of fielded collective protection systems that are smaller, lighter, less costly to produce and maintain, and more logistically supportable, enabling mission accomplishment in spaces safe from the effects of chemical, biological, and radiological (CBR) contamination. - Decontamination (DE7): technology refresh of fielded Contamination Mitigation (ConMit) systems that will remove and/or detoxify contaminated material without damaging combat equipment, personnel, or the environment. - Individual Protection (IP7): technology refresh of fielded individual protective equipment which enable the Joint Force to operate in a contaminated CBR environment with little or no degradation to performance. - Information Systems (IS7): technology refresh, modernization and continuous engineering of software applications and information systems to shape and inform the battlespace against CBRN threats. - Medical Biological Defense (MB7): technology refresh of fielded medical diagnostic systems and associated capabilities (e.g., assays) that contribute to the layered medical defenses against biological warfare agent and fielded medical nerve agent treatment system threats facing U.S. Forces in the field. - Medical Chemical Defense (MC7): technology upgrade of fielded medical nerve agent treatment system that contribute to the layered medical defenses against chemical warfare agent threats facing U.S. Forces in the field. - Test and Evaluation (TE7): technology upgrades and revitalization of fielded test capabilities and infrastructure at Dugway Proving Ground necessary to evaluate CBRN Defense systems in realistic operating environments. The projects in this PE support operational systems development necessary to maintain operational effectiveness and are therefore correctly placed in Budget Activity 7.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2022
Source ID
0607384BP_7_0400_PB_2022
Change Summary Explanation
Funding: FY20 (-$0.008 Million): Reprogramming adjustments to balance overall portfolio efforts. FY20 (-$1.118 Million) Transfer of funding to support Small Business Innovative Research/Small Business Technology Transfer efforts. FY22 (+$15.279 Million): Increase supports Reactive Chemistry Orthogonal Surface and Environmental Threat Ticket Array acceleration, and efforts to reduce hazard for aircrew respiratory and ocular protection on Modernization Individual Protection programs (+$16.423 Million). Departmental inflation/travel adjustments (-$1.144 Million). Schedule: N/A Technical: N/A
Service Agency Name
Chemical and Biological Defense Program

Tags

Communities of Interest

  • Biomedical
  • Ground and Sea Platforms

DTIC Thesaurus Topics

  • Application Software
  • Chemical Detection
  • Chemical Warfare
  • Chemical Warfare Agents
  • Command And Control
  • Detection
  • Detectors
  • Information Exchange
  • Information Systems
  • Personal Protective Equipment
  • Protective Equipment
  • Test And Evaluation
  • Test Equipment
  • Test Facilities
  • Warfare
  • Warning Systems
  • Weapons Of Mass Destruction

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.

Technology Areas

  • Space

Related Documents